Neoadjuvant chemotherapy in locally advanced carcinomas of the breast: Tumour regression and perioperative complications;Neoadjuvante Chemotherapie bei lokal fortgeschrittenen Mammakarzinomen: Tumorregression und perioperative Komplikationen

Geburtshilfe und Frauenheilkunde

Volumn 58, Issue 1, 1998, Pages 44-50

  Wallwiener, D ^a   Diel, I J ^a   Solomayer, E F ^a   Schoenmakers, C ^a   Crischke, E M ^a   Junkermann, H ^a   Sinn, H P ^a   Kaufmann, M ^a   Basiert, G ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER SURGERY; CONSERVATIVE TREATMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PEROPERATIVE COMPLICATION; POSTMENOPAUSE; PREMENOPAUSE; SEROMA; TUMOR REGRESSION; WOUND INFECTION;

EID: 0031914748     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1022119     Document Type: Article

References (33)

1. Basiert, G., D. Wallwiener, I. J. Diel, E.-M. Grischke, H. Schmid: Aktuelle Aspekte der gynäkologischen Onkologie an der Jahrtausendwende. Onkologe 2 (1996) 25-30.
2. Belembaogo, L. V. Feillel, P. Chollet, H. Cure. P. Verrelle, F. Kwiatkowski, J. L Achard, G. Le-Bouedec, J. Chassagne, Y. J. Bignon: Neoadjuvant chemotherapy in 126 operable breast cancers. Eur. J. Cancer 28 A ( 1992) 896 - 900.
3. Bonadonna, G.: Conceptual and practical advances in the management of breast cancer. J. Clin. Oncol. 7 (1989) 1380-1397.
4. Bonadonna, G.: Evolving concepts in the systemic adjuvant treatment of breast cancer. Cancer Res. 52 (1992) 2127-2137.
5. Bonadonna. G., P. Valagussa: Combined modality approach for high-risk breast cancer. The Milan Cancer Institute experience. Surg. Oncol. Clin. N. Amer. 4 (1995 A) 701 -714.
6. Bonadonna, G., P. Valagussa, R. Zucali, B. Salvadori: Primary chemotherapy in surgically resectable breast cancer. CA Cancer J. Clin. 45 (19958)227-243.
7. Booser, D. J., G. N. Hortobagyi: Treatment of locally advanced breast cancer. Semin. Oncol. 19 (1992) 278-285.
8. Broadwater.J. R.. M.J. Edwards. C. Kuglen, G. N. Hortobagyi, F. C. Ames, C. M. Balch: Mastectomy following preoperative chemotherapy: Strict operative criteria control operative morbidity. Ann. Surg. 213 (1991 ) 126-129.
9. Calais. G., C. Berger, P. Descamps. S. Chapet, A. ReynoudBougnoux. G. Body, P. Bougnoux, J. Lansac. O. Le Floch: Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74 (1994) 1283-1288.
10. Carter, C. L, C. Allen, D. E. Henson: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63(1989)181-187.
11. DeVita. V. T.: Primary Chemotherapy Can Avoid Mastectomy, but There Is More to It Than That. J. Nath. Cancer Inst. 82 (1990) 1522-1524.
12. Diel, I. J., B. Gruber-Hoffmann, E.-F. Solomayer, S. D. Costa, D. Wallwiener, H. Schmid, H. Junkermann, M. Kaufmann, G. Bastert: Immunzytologischer Tumorzellnachweis im Knochenmark bei Patientinnen mit Mammakarzinom nach neoadjuvanter Chemotherapie. In Kreienberg, R., H.-J. Grill, V. Möbus, W. Koldovsky (Hrsg.): Aktuelle Aspekte der Tumorimmunologie in der Gynä kologie. W. Zuckschwerdt, München, Berlin, Wien 1995 (196202).
13. Fisher, B., D. L Wickerham, C. Redmond: Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer. Semin. Oncol. 19 (1992) 263-277.
14. Fisher, B., H. Rockette, A. Robidoux, R. Margolese, A. Cruz. J. Hoehn, D. Boysen, E. Mamounas, D. L Wickerham, A. DeCillis: Effect of preoperative therapy for breast cancer on local-regional disease: First report of NSABP B-18. Proc. Amer. Soc. Clin. Oncol. 13 (1994) 64 Abstract.
15. Fisher, B., A. Brown, E. Mamounas, S. Wieand, E. Fisher, A. Robidoux, R. Margolese, A. Cruz, D. L Wickerham, N. Wolmark: Effect of preoperative therapy for primary breast cancer (BC) on local-regional disease, disease-free survival and survival: results from NSABP B-18. Proc. Amer. Soc. Clin. Oncol. 16 (1997) 449 Abstract.
16. Forrest. A. P., P. A. Levack, U. Chetty, R. A. Hawkins, W. R. Miller, J. F. Smith, T. J. Anderson: A human tumour model. Lancet 2 (1986) 840-842.
17. Guenier, C, M. Coibion, A. Badr El Din, J. M. Norgaret, I. Lorent, E. Toueni, P. Vanhoute, W. Mattheiem: Morbidity of surgical treatment for advanced breast cancer after irradiation. Ann. Chir. 44(1990)392-395.
18. Hortobagyi, G. N.: Multidisciplinary management of advanced primary and metastatic disease. Cancer 74 (Suppl. 1) (1994) 416-423.
19. Jacquillat, C, M. Weil. F. Baillet, C. Bore!, G. Auclerc. M. A. DeMaublanc, M. Housset, G. Forget, L Thill. C. Soubrane, D. Khayat: Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66 (1990) 119-129.
20. Kurtz, J. M.: Should surgery remain the initial treatment of "operable" breast cancer? Eur.J. Cancer 27 (1991) 1539-1542.
21. Mauriac, L, M. Durand, A. Avril, J. M. Dilhuydy: Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm: Results of a randomized trial in a single centre. Ann. Oncol. 2 (1991) 347-354.
22. O'Brien, M. E. R., I. E. Smith: The prognostic implications of chemotherapy in the treatment of breast cancer. Current Opinion in Obstetrics and Gynecology 8 (1996) 21 -26.
23. Powles, T. J., T. F. Hickish, A. Makris, S. E. Ashley. M. E. R. O'Brien, V. A. Tidy, S. Casey, A. G. Nash, N. Sacks, D. Cosgrove, D. MacVicar, I. Fernando, H. T. Ford: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J. Clin. Oncol. 13 (1995) 547-552.
24. Sataloff. D. M., B. A. Mason, A. J. Prestipino, U. L Seinige, C. P. Lieber, Z. Baloch: Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J. Amer. Coll. Surg. 180 (1995) 297-306.
25. Sauter, E. R., B. L Eisenberg, J. P. Hoffman, F. D. Ottery, M. C. Boraas, L J. Goldstein. L J. Solin, D. W. Kinne: Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World. J. Surg. 17 (1993)237-242.
26. Scholl, S. M., B. Asselain, T. Palangie, T. Dorval, M. Jouve, E. G. Giralt, J. Vilcoq, J. C. Durand, P. Pouillart: Neoadjuvant chemotherapy in operable breast cancer. Eur. J. Cancer 27 (1991) 1668-1671.
27. Scholl, S. M., A. Fourquet, B. Asselain, J. Y. Pierga.J. R. Vilcoq. J. C Durad, T. Dorval, T. Palangie, M. Jouve, P. Beuzeboc, E. GarcioGiralt, R. J. Salmon, A. De la Rochefordiere, F. Campana, P. Pouillart: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur.J. Cancer 30 A (1994) 645-652.
28. Schwartz, G. F., C. A. Birchansky, L T. Komarnicky, C. M. Mansfield, R. I. Cantor, W. A. Biermann, F. M. Fellin, J. McFarlane: Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73 (1994) 362-369.
29. Semiglazov, V. F., E. E. Topuzov, J. L Bavli, V. M. Moiseyenko, 0. A. Ivanova, I. K. Seleznev, A. A. Orlov, N. Y. Barash, 0. M. Golubeva, 0. F. Chepic: Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IlbIHa breast cancer. Ann. Oncol. 5 (1994) 591 -595.
30. Sinn, H. P., H. Schmid, H. Junkermann, J. Huober, G. Leppien, M. Kaufmann, G. Basiert, H. F. Otto: Histologische Régression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie. Geburtsh. u. Frauenheilk. 54 (1994) 552-558.
31. Smith. I. E., A. L Jones. M. E. R. O'Brien, J. A. McKinna, N. Sacks, M. Baum: Primary medical (néo-adjuvant) chemotherapy for operable breast cancer. Eur. J. Cancer 29 A (1993) 1796 -1799.
32. Smith, I. E., G. Walsh, A. Jones. J. Prendiville, S. Johnston, B. Gusterson, F. Ramage, H. Robertshaw, N. Sacks, S. Ebbs, J. A. McKinna, M. Baum: High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J. clin. Oncol. 13 (1995)424-429.
33. Veronesi, U., G. Bonadonna, S. Zurrida, V. Galimberti, M. Greco, C. Brambilla, A. Luini, S. Andreola, F. Rilke, R. Raselli. M. Merson, V. Sacchini, R. Agresti, A. Luini, S. Andreola, F. Rilke, R. Raselli, M. Merson, V. Sacchini, R. Agresti: Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann. Surg. 222 (1995) 612-618.